Johnson & Johnson's $13.1 Billion Acquisition of Shockwave Medical Expands MedTech Portfolio
TL;DR
Johnson & Johnson has acquired Shockwave Medical for $13.1 billion, aiming to bolster its presence in higher-growth markets and expand its expertise in cardiovascular intervention. Shockwave Medical specializes in intravascular lithotripsy, a technology that helps treat calcifications in the arteries, and the deal is expected to close in mid-2024. The acquisition is projected to be slightly dilutive to J&J's adjusted earnings for this year and the next, and analysts believe the offer fairly values Shockwave, with no anticipated antitrust issues due to a lack of product overlap.
Topics:businessbusiness-healthcare#acquisition#business-healthcare#cardiovascular-technology#johnson-and-johnson#medtech#shockwave-medical
- Johnson & Johnson To Buy Shockwave Medical For $13.1 Billion Investor's Business Daily
- Johnson & Johnson boosts heart device business with $12.5 billion Shockwave Medical deal CNBC
- J&J to pump another $13B into its MedTech business with Shockwave deal ABC News
- J&J to buy Shockwave Medical in $13.1 billion acquisition USA TODAY
- Johnson & Johnson to Buy Shockwave Medical. It's a Cardio Health Play. Barron's
Want the full story? Read the original reporting
Read on Investor's Business Daily